[1]
Leon-rodriguez, E. and Rivera-franco, M.M. 2018. ORAL CYCLOSPORINE AS AN ALTERNATIVE FOR INITIAL STANDARD PROPHYLAXIS IN ALLOGENEIC STEM CELL TRANSPLANTATION WHEN INTRAVENOUS FORMULATION IS UNAVAILABLE. Asian Journal of Pharmaceutical and Clinical Research. 11, 12 (Dec. 2018), 108–111. DOI:https://doi.org/10.22159/ajpcr.2018.v11i12.27049.